Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results - Wikidata - wikimedia - TriplyDB

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

http://www.wikidata.org/entity/Q35465478

about

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study Diabetic Retinopathy: Animal Models, Therapies, and Perspectives Updates on the Clinical Trials in Diabetic Macular Edema Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?Pericytes, an overlooked player in vascular pathobiology Current perspectives on ranibizumab Diabetic macular oedema: evidence-based treatment recommendations for Asian countries.Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema New Therapeutic Approaches in Diabetic Retinopathy.Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease A Review of Ranibizumab for the Treatment of Diabetic Retinopathy.Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis Telemedicine in diabetic retinopathy: current status and future directions.[Diabetic maculopathy].Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy.Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy.Use of flucinolone acetonide for patients with diabetic macular oedema: patient selection criteria and early outcomes in real world setting Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema Recent advancements in diabetic retinopathy treatment from the Diabetic Retinopathy Clinical Research Network [Diagnosis, treatment and monitoring of diabetic eye control].Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review.[National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial.Visual outcome of laser treatment in diabetic macular edema: Study from an Urban Diabetes Care Center Evidence-Based Treatment of Diabetic Macular Edema.Therapeutic Options in Refractory Diabetic Macular Oedema.Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review.Identification of time point to best define 'sub-optimal response' following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data.Diabetic Retinopathy: Battling the Global Epidemic.Patients' preferences for involvement in the decision-making process for treating diabetic retinopathy.Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature.Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents

P2860

Q24658546-1EBCD609-CAA3-41FB-B788-85CF7F585DEF Q26765466-7976912A-CDCD-4E4B-AA81-24930C4C5562 Q26767100-1DBD3B82-B83B-48E5-BA09-7CA7EC7307D9 Q26775853-401394DC-007B-4EC0-ACE0-AF99ADA8911E Q28049700-04BFEE46-A367-4046-AE7E-1A61FFF37453 Q28066675-B7F56648-C8C0-4B6F-B520-15831364B2B8 Q28070053-06A582AB-A4FB-4283-9798-0248D005468B Q28082383-EC0E44C3-1A81-454D-8AAB-4105E457A56B Q30101045-47AE56F2-FD25-4F21-A812-77A3A8D8B13F Q33563100-60DD27B5-1FEA-49D4-910A-D4172C2481D5 Q33583037-219397DD-F9FE-439A-B515-CD755E4E1D04 Q33705724-0B98D5DD-D249-420B-8E1C-CAAC7FF7F5FD Q33740152-AD0DB8A8-DAD9-43A7-8CFC-F9F83371390F Q33912485-EFF4A2D8-C56E-44C9-8EAA-415C3E78741D Q35544166-43270C69-F317-406C-8630-C745AE604E0C Q35792895-971919A8-FC08-4B89-B3B6-DDFD4CD91B5A Q35870506-F6169E21-28F9-4110-AE38-7ECF8E1581DF Q35877402-0DE995F1-EAAC-48DD-B30E-1637925C16B6 Q35884438-2C5FBCF4-C1E5-4F71-9711-F0EDE9C28910 Q35902351-917AB493-B513-477D-A583-734CB19361FC Q35935370-F81039E8-8F8B-407B-BFB8-3213BA99C0E6 Q35981628-BA836CBE-EC4B-49FC-AFBA-E8C3FB0FD9C1 Q35984696-2F30A378-B354-4B87-B89C-B8AE384E3045 Q36063335-FF300818-9275-4955-8E3E-0B4E148BAF2F Q36155647-E7DBDEE4-3B2C-45A8-9B69-5DB34662FC3A Q36203135-A1350FBD-832D-4108-AEF9-2CE97E8FCEB6 Q36242390-BD249DFA-E22E-43BC-8D30-CC7FEAEF38CE Q36280656-F9631321-4934-4321-8A32-4EE2B9EFA406 Q36307731-44346885-FA8A-4A5C-A912-89372B59C79E Q36324841-DF727B80-F6D7-4D49-92B8-A14AA512C40C Q36407311-BB0011FD-95DB-45B1-8C5C-FA4FEF4975CB Q37494858-DF53C4A6-BD1F-4BEB-AC10-81DBD26DAEA2 Q38372446-339EFFA4-BE7B-4683-B697-43CD6A496BA8 Q38845769-4222DFE1-E175-4A13-8B14-AB742978595B Q38912755-EBCC2BB6-1074-4DC3-9474-2E94937A4A88 Q38937864-4BD6682E-FB06-4B8C-B854-4B575F32BCCE Q39103989-E2070040-1368-47D4-9F6C-77A415A5A535 Q39292954-EBB8EF6D-1983-4C2E-BC28-82D2DD736DF7 Q41494022-C6901DB1-C993-4C2D-955A-F0E9578728E7 Q41998002-D5420A5B-D34F-4E17-A761-A5D8B492EC7C

P2860

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

http://www.wikidata.org/entity/Q35465478

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Intravitreal Ranibizumab for d ...... -year randomized trial results

@ast

Intravitreal Ranibizumab for d ...... -year randomized trial results

@en

type

label

Intravitreal Ranibizumab for d ...... -year randomized trial results

@ast

Intravitreal Ranibizumab for d ...... -year randomized trial results

@en

prefLabel

Intravitreal Ranibizumab for d ...... -year randomized trial results

@ast

Intravitreal Ranibizumab for d ...... -year randomized trial results

@en

P1433

Q35465478-A8D5B2C6-A392-4FCE-8B5E-DDAA63E3B237

P1476

Q35465478-D9971DB8-24C7-454A-879A-F3804A60AFE5

P2093

Q35465478-09026360-A3C7-4845-BC76-43D477914FAB

Q35465478-13231C81-F8A3-42F3-A946-2057AEC7AB06

Q35465478-3EFABC37-F8A4-4417-A11F-09FB4F9AD685

Q35465478-542E0929-8309-4ADB-A2ED-7CEDCB8CF074

Q35465478-580C3BCA-7E49-4383-A0AC-63A80281266C

Q35465478-731FFA94-8B5C-4936-A223-1E8D2FDB90FB

Q35465478-C5172A89-BD91-40B2-9F28-9E9E9830E69A

Q35465478-D509A5BD-A7CE-46F9-B95C-150E3C6F69CA

Q35465478-E8D27DC9-4AF3-41B7-A564-AC7BC621C118

P2860

Q35465478-6DCB7926-DABE-488B-8C50-FE573321E820

Q35465478-A8179531-91E8-4A0B-890A-02E65BCC37DB

Q35465478-C963366C-A279-4D8F-92A6-9E3A2197CC64

Q35465478-CF36F329-AC72-4D02-A231-55A95194E8EC

Q35465478-D8F2039E-F21F-4653-9393-55BDA044A6CF

P304

Q35465478-A9B0F155-EBDC-43DC-9957-2974C96F5812

P31

Q35465478-0FF0DD75-BF8C-4975-B19D-E593E07B5880

P356

Q35465478-2FE70A06-07E9-4E6F-8A80-C9CB44B20021

P433

Q35465478-E20FC43A-4756-4D4B-BE13-ADB2E3106CD0

P478

Q35465478-DF66170F-644C-4CEA-90A6-7F2901C4CEE7

P577

Q35465478-DCC513A1-BF96-40C1-BEC9-D4C31A987C39

P698

Q35465478-AC9BF3A4-C020-45E9-9C46-74FC759CE207

P932

Q35465478-774D3DF1-E334-4F45-A901-B16858060D93

P356

J.OPHTHA.2014.08.047

P1433

P1476

Intravitreal Ranibizumab for d ...... -year randomized trial results

@en

P2093

Adam R Glassman

http://www.w3.org/2001/XMLSchema#string

Allison Ayala

http://www.w3.org/2001/XMLSchema#string

Christina J Flaxel

http://www.w3.org/2001/XMLSchema#string

David Browning

http://www.w3.org/2001/XMLSchema#string

Diabetic Retinopathy Clinical Research Network

http://www.w3.org/2001/XMLSchema#string

Lee M Jampol

http://www.w3.org/2001/XMLSchema#string

Michael J Elman

http://www.w3.org/2001/XMLSchema#string

Neil M Bressler

http://www.w3.org/2001/XMLSchema#string

Thomas W Stone

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.

P304

375-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2014.08.047

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25439614

http://www.w3.org/2001/XMLSchema#string

P932

4520307

http://www.w3.org/2001/XMLSchema#string